About this Journal Submit a Manuscript Table of Contents
Autoimmune Diseases
Volume 2012 (2012), Article ID 296214, 7 pages
http://dx.doi.org/10.1155/2012/296214
Research Article

Autoantibodies in Senear-Usher Syndrome: Cross-Reactivity or Multiple Autoimmunity?

Department of Immunology, Universidad Autónoma de Zacatecas, Chepinque 306, Colonia Lomas de la Soledad, 98040 Zacatecas, ZAC, Mexico

Received 26 September 2012; Accepted 23 November 2012

Academic Editor: Ricard Cervera

Copyright © 2012 María Elena Pérez-Pérez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Grando, “Pemphigus autoimmunity: hypotheses and realities,” Autoimmunity, vol. 45, pp. 7–35, 2012.
  2. M. Amagai and J. R. Stanley, “Desmoglein as a target in skin disease and beyond,” Journal of Investigative Dermatology, vol. 132, pp. 776–784, 2012.
  3. F. E. Senear and B. Usher, “Unusual type of pemphigus combining features of lupus erythematosus,” Archives of Dermatology, vol. 13, article 761, 1926.
  4. C. Steffen and D. Thomas, “The men behind the eponym: Francis E. Senear, Barney Usher, and the Senear-Usher syndrome,” American Journal of Dermatopathology, vol. 25, no. 5, pp. 432–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. T. Roscoe, L. Diaz, S. A. P. Sampaio, et al., “Brazilian pemphogus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer,” Journal of Investigative Dermatology, vol. 85, no. 6, pp. 538–541, 1985. View at Scopus
  6. M. K. Hacker-Foegen, M. Janson, M. Amagai, J. A. Fairley, and M. S. Lin, “Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies,” Journal of Investigative Dermatology, vol. 121, no. 6, pp. 1373–1378, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Blondin, Z. Zhang, K. K. Shideler, H. Hou, M. J. Fritzler, and P. R. Mydlarski, “Prevalence of non-organ-specific autoantibodies in patients with Pemphigus vulgaris,” Journal of Cutaneous Medicine and Surgery, vol. 13, no. 2, pp. 82–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. M. Nisihara, R. S. De Bem, R. Hausberger et al., “Prevalence of autoantibodies in patients with endemic pemphigus foliaceus (fogo selvagem),” Archives of Dermatological Research, vol. 295, no. 4, pp. 133–137, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Zagorodniuk, S. Weltfriend, L. Shtruminger et al., “A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris,” International Journal of Dermatology, vol. 44, no. 7, pp. 541–544, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Satoh, M. Vázquez-Del Mercado, and E. K. L. Chan, “Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases,” Modern Rheumatology, vol. 19, pp. 219–228, 2009.
  11. R. Herrera Esparza, T. Swaak, L. Aarden, and R. Smeenk, “Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal,” Journal of Rheumatology, vol. 12, no. 6, pp. 1109–1117, 1985. View at Scopus
  12. T. Chorzelski, S. Jablońska, and M. Blaszczyk, “Immunopathological investigations in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus),” British Journal of Dermatology, vol. 80, no. 4, pp. 211–217, 1968. View at Scopus
  13. D. A. Oktarina, A. M. Poot, D. Kramer, G. F. Diercks, M. F. Jonkman, and H. H. Pas, “The IgG “Lupus-Band” deposition pattern of pemphigus erythematosus: association with the desmoglein 1 ectodomain as revealed by 3 cases,” Archives of Dermatology, vol. 16, pp. 1–6, 2012.
  14. M. Amagai, K. Tsunoda, D. Zillikens, T. Nagai, and T. Nishikawa, “The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile,” Journal of the American Academy of Dermatology, vol. 40, no. 2, part 1, pp. 167–170, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. Arteaga, P. S. Prisayanh, S. J. P. Warren, Z. Liu, L. A. Diaz, and M. S. Lin, “A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3,” Journal of Investigative Dermatology, vol. 118, no. 5, pp. 806–811, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. G. C. Sharp, W. S. Irvin, R. L. LaRoque et al., “Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy,” Journal of Clinical Investigation, vol. 50, no. 2, pp. 350–359, 1971. View at Scopus
  17. A. Firooz, A. Mazhar, and A. R. Ahmed, “Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris,” Journal of the American Academy of Dermatology, vol. 31, no. 3, pp. 434–437, 1994. View at Scopus
  18. J. P. Callen, “Internal disorders associated with bullous disease of the skin. A critical review,” Journal of the American Academy of Dermatology, vol. 3, no. 2, pp. 107–119, 1980. View at Scopus
  19. B. Yalçin, E. Tamer, G. G. Toy, P. Öztas, and N. Alli, “Development of pemphigus vulgaris in a patient with vitiligo and Hashimoto's thyroiditis,” Journal of Endocrinological Investigation, vol. 28, no. 6, pp. 558–560, 2005. View at Scopus
  20. K. W. Wucherpfennig, B. Yu, K. Bhol et al., “Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 25, pp. 11935–11939, 1995. View at Scopus
  21. K. W. Wucherpfennig and J. L. Strominger, “Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases,” Journal of Experimental Medicine, vol. 181, no. 5, pp. 1597–1601, 1995. View at Scopus
  22. J. Silver and S. M. Goyert, “Epitopes are the functional units of Ia molecules and form the molecular basis for disease susceptibility,” in Human Class II Histocompatibility Antigens, S. Ferrone, B. G. Solheim, and E. Moller, Eds., pp. 32–48, Springer, Berlin, Germany, 1985.
  23. P. K. Gregersen, J. Silver, and R. J. Winchester, “The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis,” Arthritis and Rheumatism, vol. 30, no. 11, pp. 1205–1213, 1987. View at Scopus
  24. L. R. Zakka, D. B. Keskin, P. Reche, and A. R. Ahmed, “Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously,” Clinical and Experimental Immunology, vol. 162, no. 2, pp. 224–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. J. Scharf, A. Friedmann, C. Brautbar et al., “HLA class II allelic variation and susceptibility to pemphigus vulgaris,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 10, pp. 3504–3508, 1988. View at Scopus
  26. K. W. Wucherpfennig and D. Sethi, “T cell receptor recognition of self and foreign antigens in the induction of autoimmunity,” Seminars in Immunology, vol. 23, no. 2, pp. 84–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Fridkis-Hareli, “Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases,” Journal of Autoimmune Diseases, vol. 5, article 1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. L. R. Zakka, P. A. Reche, and R. Ahmed, “The molecular basis for the presence of two autoimmune diseases occurring simultaneously—preliminary observations based on computer analysis,” Autoimmunity, vol. 45, pp. 253–263, 2012.